# Chronic Kidney Disease (CKD) Platelet Study

> **NCT03649711** · PHASE3 · COMPLETED · sponsor: **University of Arkansas** · enrollment: 76 (actual)

## Conditions studied

- Chronic Kidney Diseases
- Heart Attack
- Stroke, Ischemic

## Interventions

- **DRUG:** Ticagrelor 90mg
- **DRUG:** Clopidogrel 75mg
- **DRUG:** Aspirin 81 mg

## Key facts

- **NCT ID:** NCT03649711
- **Lead sponsor:** University of Arkansas
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2018-11-01
- **Primary completion:** 2021-09-02
- **Final completion:** 2021-09-02
- **Target enrollment:** 76 (ACTUAL)
- **Last updated:** 2022-12-29

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03649711

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03649711, "Chronic Kidney Disease (CKD) Platelet Study". Retrieved via AI Analytics 2026-05-23 from https://api.ai-analytics.org/clinical/NCT03649711. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*